Thomas T.

Thomas T. is an accomplished professional with a strong background in the life sciences and a focus on improving patient outcomes, particularly for rare diseases. Currently serving as a Board Member at Theolytics and Board Observer at multiple organizations including AbolerIS Pharma, Teitur Trophics, Breye Therapeutics ApS, and VarmX, Thomas has demonstrated a commitment to leveraging scientific advancements for patient benefit. Previous experience includes roles as Principal at Sound Bioventures and Senior Principal at Lundbeckfonden Ventures, along with Board Member positions at VarmX and Atox Bio. Thomas holds a D.Phil. in Immunology from the University of Oxford, a recent credential in Private Equity and Venture Capital from Harvard Business School, and a diploma in Board Leadership from CBS Bestyrelsesuddannelserne, complemented by an M.Sc. in Biochemistry from the University of Copenhagen.